Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05205460
Other study ID # A202105159
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 12, 2021
Est. completion date October 8, 2024

Study information

Verified date November 2023
Source Tri-Service General Hospital
Contact Chia-Ying Lai, MD
Phone 886-2-87923311
Email pokerface165@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of our study is to investigate the effectiveness of telehealth exercise training programs in Post-COVID patients.


Description:

Decreased exercise capacity, persistent dyspnea and easily fatigue are found in some Post-COVID patients. Telerehabilitation has been developed in cardiac and pulmonary diseases such as coronary artery disease and chronic obstructive pulmonary disease for years with good clinical outcomes. However, little is known about the effectiveness of home-based telehealth exercise training programs among Post-COVID patients. Thus, we want to investigate the effectiveness of telehealth exercise training programs among Post-COVID patients, including exercise capacity, physical amounts and health related quality of life.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date October 8, 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria: Individuals who had been diagnosed with COVID-19 positive and whose last PCR test or rapid antigen test was negative with the following criteria: - aged between 20 to 80 years old - persistent symptoms at least 4 weeks after recovery from COVID-19 infection, including any of the following symptoms: dyspnea, fatigue, cough, headache, chest tightness, palpitations, loss of smell, anxiety, insomnia, brain fog or joint pain - able to speak and understand Mandarin - no cognitive impairment (Mini-Mental State Examination > 24) - able to walk including those who need the walking aid - had mobile phones and could easily access the Internet Exclusion Criteria: - a history of chronic obstructive pulmonary disease or other respiratory diseases - a history of arrhythmia,cancer, end-stage renal disease with dialysis, being diagnosed with mental illness, recent stroke within 6 months - inability to participate because of comorbid neurological or musculoskeletal conditions that produce moderate to severe physical disability - need all day oxygen support

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Home-based telehealth exercise training program
A home-based exercise mobile app will be offered combined with the heart rate sensing clothes to each participant in the group of home-based telehealth exercise training program. The mobile app provides auto-feedback of heart rate at each exercise training session through the heart rate sensing clothes and alarm function identifying individuals' appropriate exercise intensity (target heart rate) during their exercise based on their exercise prescription calculated and set up inside the app. After completing each exercise training session, the record of training time and heart rate response is simultaneously uploaded to the cloud system of the medical center through the heart rate sensing clothes. The experienced and well-trained nurse checked the cloud system data to monitor participants' adherence to exercise training. In addition, online communication is enabled using LINE software, which provided a platform for patients and researchers to interact with each other through messaging.
Behavioral:
Education and self-exercise
The participants will receive a exercise prescription suggestion. Then, they will maintain their routine outpatient follow-up per month and usual lifestyles with weekly reminders.

Locations

Country Name City State
Taiwan Tri-service general hospital Taipei Neihu

Sponsors (1)

Lead Sponsor Collaborator
Tri-Service General Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in exercise capacity: peak oxygen uptake (VO2peak) The peak oxygen uptake (VO2peak) is measured by graded exercise testing. A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2). 3 months
Primary Change in exercise capacity: workload (Watt) The workload (Watt) is measured by graded exercise testing. A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2). 3 months
Primary Change in exercise capacity: anaerobic threshold (AT) The anaerobic threshold (AT) is measured by graded exercise testing. A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2). 3 months
Secondary Change in Physical Activity Amounts: Taiwan version of the International Physical Activity Questionnaire Taiwan version of the International Physical Activity Questionnaire. The overall physical activity (MET-min/week), vigorous intensity physical activity (MET-min/week), moderate intensity physical activity (MET-min/week), walking (MET-min/week), and sitting behavior (min/week) are measured. 3 months
Secondary Change in confidence level of exercise: Questionnaire of Self-Efficacy Items Questionnaire of Self-Efficacy Items. A five-item self-efficacy measure designed to measure confidence in one's ability to persist with exercising in various situations was developed. A five-point scale is used to rate each item : 1 indicates "not at all confident", 2 indicates "little confident" , 3 indicates "confident", 4 indicates "very confident", 5 indicates "strongly confident". 3 months
Secondary Change in Health-Related Quality of Life: Taiwan version of World Health Organization Quality-of-Life Questionnaire (WHOQOL-BREF) The WHOQOL-BREF Taiwan version is simplified from the WHOQOL long form for Taiwan. It contains 28 items. ( 26 items organized into 4 domains, and 2 items on overall quality of life and general health) The 4 domains are Physical Health, Psychological, Social Relationships and Environment. Three negatively phrased items are reversed scored. Domain scores are computed by taking the mean of the scores of the items that constitute the domain and multiplied by 4 so that the scores are directly comparable with those derived from WHOQOL-100. 3 months
Secondary Change in sleep quality: Pittsburgh Sleep Quality Index (PSQI) Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances over a l-month time interval. Nineteen individual items generate seven "component" scores and the sum of scores for these seven components yields one global score. (Scores ranged from 0 to 21, with higher scores indicating poor sleep quality.) 3 months
Secondary Change in lung function: Forced expiratory volume 1 (FEV1) The amount of air exhaled (mL) during the first second during a forced expiratory volume test will be measured by spirometry. 3 months
Secondary Change in lung function: Forced Vital Capacity (FVC) The total amount of air exhaled (mL) during a forced expiratory volume test will be measured by spirometry. 3 months
Secondary Change in lung function: FEV1/FVC % The measured FEV1 is divided by the measured FVC. 3 months
Secondary Change in lung function: Total lung capacity Total lung capacity (TLC) is the maximum volume of air the lungs can hold and is measured by lung plethysmography. 3 months
Secondary Change in ventilation/ perfusion abnormalities (VE/VCO2) The ventilation/ perfusion abnormalities (VE/VCO2)is measured by graded exercise testing.
A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2).
3 months
Secondary Change in left ventricular function: O2 pulse O2 Pulse is simply oxygen consumption (in ml) divided by heart rate. It is used as an index of stroke volume. The O2 pulse is measured by graded exercise testing. A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2). 3 months
Secondary Change in heart rate recovery The heart rate recovery is measured by graded exercise testing, including 1 minute and 2 minute recovery.
A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2).
3 months
Secondary Change in maximal heart rate (HRmax) The maximal heart rate is measured by graded exercise testing, including 1 minute and 2 minute recovery. A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2). 3 months
Secondary Change in maximal blood pressure (BPmax) The maximal heart rate is measured by graded exercise testing, including 1 minute and 2 minute recovery.
A motorized ergometer bike (Ergoselect 200 K, Ergoline, Germany) is used for cardiopulmonary testing with a incremental ramp protocol (10-W/min). The test will be terminated until patients complained of physical exhaustion or maximal capacity (respiratory exchange ratio (RER) meets 1.2).
3 months
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure